Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CRSP
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 47,837 | $49.78 | $2.4M Sale | Form 4 ↗ |
| Oct 14, 2026 | George Simeon Director | CRSP CRISPR Therapeutics AG | Sale | 14,514 | $49.63 | $720.4K Sale | Form 4 ↗ |
| Sep 22, 2026 | James R. Kasinger General Counsel and Secretary | CRSP CRISPR Therapeutics AG | Sale | 10,400 | $60.24 | $626.5K Sale | Form 4 ↗ |
| Sep 17, 2026 | Ali Behbahani Director | CRSP CRISPR Therapeutics AG | Sale | 13,679 | $57.09 | $780.9K Sale | Form 4 ↗ |
| May 29, 2026 | Naimish Patel Chief Medical Officer | CRSP CRISPR Therapeutics AG | Sale | 3,786 | $55.62 | $210.6K Sale | Form 4 ↗ |
| Mar 23, 2026 | James R. Kasinger General Counsel and Secretary | CRSP CRISPR Therapeutics AG | Sale | 3,182 | $46.78 | $148.9K Sale | Form 4 ↗ |
| Mar 23, 2026 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 10,020 | $46.78 | $468.7K Sale | Form 4 ↗ |
| Mar 23, 2026 | Raju Prasad Chief Financial Officer | CRSP CRISPR Therapeutics AG | Sale | 3,708 | $46.78 | $173.5K Sale | Form 4 ↗ |
| Mar 16, 2026 | Naimish Patel Chief Medical Officer | CRSP CRISPR Therapeutics AG | Sale | 3,150 | $48.26 | $152.0K Sale | Form 4 ↗ |
| Mar 16, 2026 | Raju Prasad Chief Financial Officer | CRSP CRISPR Therapeutics AG | Sale | 4,021 | $48.26 | $194.1K Sale | Form 4 ↗ |
| Mar 16, 2026 | Raju Prasad Chief Financial Officer | CRSP CRISPR Therapeutics AG | Sale | 5,848 | $48.26 | $282.2K Sale | Form 4 ↗ |
| Mar 16, 2026 | James R. Kasinger General Counsel and Secretary | CRSP CRISPR Therapeutics AG | Sale | 3,450 | $48.26 | $166.5K Sale | Form 4 ↗ |
| Mar 16, 2026 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 10,349 | $48.26 | $499.4K Sale | Form 4 ↗ |
| Mar 11, 2026 | James R. Kasinger General Counsel and Secretary | CRSP CRISPR Therapeutics AG | Sale | 2,800 | $52.80 | $147.8K Sale | Form 4 ↗ |
| Mar 11, 2026 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 9,798 | $52.80 | $517.3K Sale | Form 4 ↗ |
| Feb 19, 2026 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 6,967 | $52.58 | $366.3K Sale | Form 4 ↗ |
| Feb 19, 2026 | James R. Kasinger General Counsel and Secretary | CRSP CRISPR Therapeutics AG | Sale | 2,112 | $52.58 | $111.0K Sale | Form 4 ↗ |
| Jan 22, 2026 | Raju Prasad Chief Financial Officer | CRSP CRISPR Therapeutics AG | Sale | 34,972 | $60.19 | $2.1M Sale | Form 4 ↗ |
| Jan 22, 2026 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 60,000 | $60.23 | $3.6M Sale | Form 4 ↗ |
| Jan 20, 2026 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 8,567 | $52.10 | $446.3K Sale | Form 4 ↗ |
| Jan 20, 2026 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 21,433 | $51.61 | $1.1M Sale | Form 4 ↗ |
| Jan 6, 2026 | Raju Prasad Chief Financial Officer | CRSP CRISPR Therapeutics AG | Sale | 5,763 | $60.21 | $347.0K Sale | Form 4 ↗ |
| Jan 6, 2026 | Raju Prasad Chief Financial Officer | CRSP CRISPR Therapeutics AG | Sale | 5,004 | $60.00 | $300.2K Sale | Form 4 ↗ |
| Jan 6, 2026 | Raju Prasad Chief Financial Officer | CRSP CRISPR Therapeutics AG | Sale | 18,933 | $60.18 | $1.1M Sale | Form 4 ↗ |
| Dec 22, 2025 | Raju Prasad Chief Financial Officer | CRSP CRISPR Therapeutics AG | Sale | 1,000 | $56.89 | $56.9K Sale | Form 4 ↗ |
| Dec 22, 2025 | Raju Prasad Chief Financial Officer | CRSP CRISPR Therapeutics AG | Sale | 5,472 | $56.33 | $308.2K Sale | Form 4 ↗ |
| Dec 22, 2025 | Raju Prasad Chief Financial Officer | CRSP CRISPR Therapeutics AG | Sale | 3,528 | $55.10 | $194.4K Sale | Form 4 ↗ |
| Oct 17, 2025 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 50,895 | $67.91 | $3.5M Sale | Form 4 ↗ |
| Oct 14, 2025 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 4,242 | $66.60 | $282.5K Sale | Form 4 ↗ |
| Oct 14, 2025 | James R. Kasinger General Counsel and Secretary | CRSP CRISPR Therapeutics AG | Sale | 1,076 | $66.60 | $71.7K Sale | Form 4 ↗ |
| Aug 18, 2025 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 13,081 | $58.15 | $760.7K Sale | Form 4 ↗ |
| Aug 6, 2025 | Douglas A. Treco Director | CRSP CRISPR Therapeutics AG | Buy | 20,000 | $57.03 | $1.1M Buy | Form 4 ↗ |
| Jul 16, 2025 | George Simeon Director | CRSP CRISPR Therapeutics AG | Buy | 960,983 | $52.03 | $50.0M Buy | Form 4 ↗ |
| Jul 16, 2025 | George Simeon Director | CRSP CRISPR Therapeutics AG | Buy | 22,319 | $52.03 | $1.2M Buy | Form 4 ↗ |
| Jul 16, 2025 | George Simeon Director | CRSP CRISPR Therapeutics AG | Buy | 6,510 | $52.03 | $338.7K Buy | Form 4 ↗ |
| May 29, 2025 | Naimish Patel Chief Medical Officer | CRSP CRISPR Therapeutics AG | Sale | 3,932 | $35.94 | $141.3K Sale | Form 4 ↗ |
| Apr 3, 2025 | Naimish Patel Chief Medical Officer | CRSP CRISPR Therapeutics AG | Buy | 1,508 | $32.96 | $49.7K Buy | Form 4 ↗ |
| Mar 21, 2025 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 10,031 | $41.23 | $413.6K Sale | Form 4 ↗ |
| Mar 21, 2025 | Julianne Bruno Chief Operating Officer | CRSP CRISPR Therapeutics AG | Sale | 1,714 | $41.23 | $70.7K Sale | Form 4 ↗ |
| Mar 21, 2025 | Raju Prasad Chief Financial Officer | CRSP CRISPR Therapeutics AG | Sale | 2,197 | $41.23 | $90.6K Sale | Form 4 ↗ |
| Mar 21, 2025 | James R. Kasinger General Counsel and Secretary | CRSP CRISPR Therapeutics AG | Sale | 3,185 | $41.23 | $131.3K Sale | Form 4 ↗ |
| Mar 17, 2025 | Raju Prasad Chief Financial Officer | CRSP CRISPR Therapeutics AG | Sale | 3,762 | $41.80 | $157.3K Sale | Form 4 ↗ |
| Mar 12, 2025 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 4,462 | $43.32 | $193.3K Sale | Form 4 ↗ |
| Mar 12, 2025 | James R. Kasinger General Counsel and Secretary | CRSP CRISPR Therapeutics AG | Sale | 1,116 | $43.32 | $48.3K Sale | Form 4 ↗ |
| Mar 12, 2025 | Julianne Bruno Chief Operating Officer | CRSP CRISPR Therapeutics AG | Sale | 190 | $43.32 | $8,231 Sale | Form 4 ↗ |
| Mar 11, 2025 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 9,973 | $42.42 | $423.1K Sale | Form 4 ↗ |
| Mar 11, 2025 | James R. Kasinger General Counsel and Secretary | CRSP CRISPR Therapeutics AG | Sale | 2,850 | $42.42 | $120.9K Sale | Form 4 ↗ |
| Mar 11, 2025 | Julianne Bruno Chief Operating Officer | CRSP CRISPR Therapeutics AG | Sale | 1,198 | $42.42 | $50.8K Sale | Form 4 ↗ |
| Feb 26, 2025 | John Greene Director | CRSP CRISPR Therapeutics AG | Buy | 7,000 | $44.85 | $313.9K Buy | Form 4 ↗ |
| Feb 19, 2025 | Samarth Kulkarni Chief Executive Officer, Director | CRSP CRISPR Therapeutics AG | Sale | 18,360 | $55.21 | $1.0M Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:34 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances